Stockmann, Philipp <br/><br/>
Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw.  [electronic resource] 

 -  Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery  Jan 2013 
 - 71-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-4119 
<br/><br/><label>Standard No.: </label>10.1016/j.jcms.2012.10.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Alleles<br/>Bisphosphonate-Associated Osteonecrosis of the Jaw--genetics<br/>Bone Density Conservation Agents--administration & dosage<br/>Case-Control Studies<br/>Drug Combinations<br/>Female<br/>Gene Frequency--genetics<br/>Genotype<br/>HLA-DQ beta-Chains--genetics<br/>HLA-DRB1 Chains--genetics<br/>Haplotypes--genetics<br/>Histocompatibility Antigens Class II--genetics<br/>Humans<br/>Injections, Intravenous<br/>Linkage Disequilibrium--genetics<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Polymorphism, Genetic--genetics<br/>Risk Factors<br/>Sex Factors